Semaglutide mastery course
Unit 8 of 12
Versus other agents
No drug is chosen in a vacuum. Semaglutide is usually weighed against tirzepatide, a dual GIP and GLP-1 agonist, and li…
Semaglutide against tirzepatide and liraglutide
No drug is chosen in a vacuum. Semaglutide is usually weighed against tirzepatide, a dual GIP and GLP-1 agonist, and liraglutide, the older daily GLP-1 agonist it largely succeeded.
This unit compares efficacy, dosing cadence, and evidence depth honestly: tirzepatide often shows greater mean weight loss, while semaglutide carries the broadest outcomes evidence and route flexibility.